Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]

Wang HH, Lee HM, Raja V, et al. J Exp Pharmacol. 2019;11:1–14.On page 13 the disclosure section should be presented as follows:DisclosureLMG is listed as an inventor on several related patents and these have been fully assigned to his institution, Stony ...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang HH (Author), Lee HM (Author), Raja V (Author), Hou W (Author), Iacono VJ (Author), Scaduto J (Author), Johnson F (Author), Golub LM (Author), Gu Y (Author)
Format: Book
Published: Dove Medical Press, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f2c8a41aafe34c5daf1133f5167f3c20
042 |a dc 
100 1 0 |a Wang HH  |e author 
700 1 0 |a Lee HM  |e author 
700 1 0 |a Raja V  |e author 
700 1 0 |a Hou W  |e author 
700 1 0 |a Iacono VJ  |e author 
700 1 0 |a Scaduto J  |e author 
700 1 0 |a Johnson F  |e author 
700 1 0 |a Golub LM  |e author 
700 1 0 |a Gu Y  |e author 
245 0 0 |a Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum] 
260 |b Dove Medical Press,   |c 2020-03-01T00:00:00Z. 
500 |a 1179-1454 
520 |a Wang HH, Lee HM, Raja V, et al. J Exp Pharmacol. 2019;11:1–14.On page 13 the disclosure section should be presented as follows:DisclosureLMG is listed as an inventor on several related patents and these have been fully assigned to his institution, Stony Brook University, The State University of New York (SUNY). FJ is also listed as an inventor on several related patents which have been fully assigned to Stony Brook University and to Chem-Master Int. Inc. on a shared basis. In addition, both LMG and FJ are minor shareholders in Traverse BioSciences, Inc., and JS is president and major shareholder in Traverse. All other authors declare that there are no conflicts of interest regarding the publication of this paper.Read the original article 
546 |a EN 
690 |a chemically-modified-curcumin 
690 |a cytokines 
690 |a matrix metalloproteinases (mmps) 
690 |a periodontitis 
690 |a rats 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Experimental Pharmacology, Vol Volume 12, Pp 73-74 (2020) 
787 0 |n https://www.dovepress.com/corrigendum-enhanced-efficacy-of-chemically-modified-curcumin-in-exper-peer-reviewed-fulltext-article-JEP 
787 0 |n https://doaj.org/toc/1179-1454 
856 4 1 |u https://doaj.org/article/f2c8a41aafe34c5daf1133f5167f3c20  |z Connect to this object online.